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A significant (>70%) number of drugs 
entering the market present low solubility 
in water1. To minimize this problem, 
which impacts on dissolution, absorption, 
and therapeutic efficacy of drugs in 
dosage forms, several techniques have 
been employed, namely micronization or 
the selection of a defined polymorph2.  
The production of amorphous solid 
dispersions of drugs is regarded as one of 
the most powerful approaches for 
solubility enhancement. However, since 
amorphous substances are 
thermodynamically unstable, they tend to 
convert back into a stable crystalline 
lattice. This conversion can be delayed by 
the combination of substances producing 
co-amorphous mixtures2,3, due to bond 
formation between individual molecules, 
thus preventing crystal formation2.  
The aim of this study was to produce a 
stable co-amorphous entity containing 
olanzapine, a poorly water soluble 
antipsychotic drug, with enhanced 
solubility in water.  
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RESULTS 
DISCUSSION AND CONCLUSIONS 
MATERIALS AND METHODS 
A 1.0g mixture composed of olanzapine and saccharin was dissolved in 
dichloromethane in a 1:1 molar ratio and the solvent was then removed 
by evaporation at 40°C.  
The resulting mixture was characterized by Fourier-transform infrared 
spectroscopy (FTIR) and near infrared spectroscopy (NIR) to detect 
possible interactions between the molecules of each compound present 
in the mixture and the combination of differential scanning calorimetry 
(DSC) with X-ray powder diffraction (XRPD) to assess the formation of 
the amorphous state of the mixture. Solubility studies were also 
performed in order to evaluate the increase in water solubility of the 
drug within the co-amorphous entity. 
Figure 1. Chemical structure of olanzapine. 
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Figure 2. Differential scanning calorimetry thermogram of 
the co-amorphous olanzapine and saccharin mixture 
Figure 3. X-ray powder diffraction of the  
co-amorphous olanzapine and saccharin mixture. 
Figure 4. FTIR spectra of the co-amorphous  
olanzapine and saccharin mixture. 
Table 1. Increased solubility of the  
co-amorphous olanzapine and saccharin mixture 
Co-amorphous mixtures offer a powerful pathway to promote the water solubility of drugs. This approach is therefore 
particularly useful for Biopharmaceutical Classification System (BCS) class II and IV drugs. Olanzapine is an antipsychotic 
BCS class II drug which shows a maximum solubility in water of only 39.0mg/L. 
The mixture olanzapine and saccharin produced by dichloromethane evaporation, characterized by combination of DSC 
and XRPD, has proven to be a co-amorphous entity. The stability of the amorphous complex is justified by the 
establishment of intermolecular bonds between the compounds present in the system. 
The co-amorphous mixture showed an increase in the water solubility of olanzapine of 114 times, as compared to the 
raw material. 
